133 related articles for article (PubMed ID: 24630047)
41. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS).
Xiao F; An D; Deng H; Chen S; Ren J; Zhou D
Seizure; 2014 Oct; 23(9):756-61. PubMed ID: 24998415
[TBL] [Abstract][Full Text] [Related]
43. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
[TBL] [Abstract][Full Text] [Related]
44. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy.
Hagemann A; May TW; Nieder E; Witte-Bölt K; Pohlmann-Eden B; Elger CE; Tergau F; Schulze-Bonhage A; Straub HB; Arnold S; Brandt C
Epilepsy Res; 2013 Mar; 104(1-2):140-50. PubMed ID: 22959715
[TBL] [Abstract][Full Text] [Related]
45. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony.
Kanemura H; Sano F; Sugita K; Aihara M
Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775
[TBL] [Abstract][Full Text] [Related]
46. Effects of levetiracetam monotherapy on sperm parameters and sex hormones: Data from newly diagnosed patients with epilepsy.
Ceylan M; Yalcin A; Bayraktutan OF; Karabulut I; Sonkaya AR
Seizure; 2016 Oct; 41():70-4. PubMed ID: 27494618
[TBL] [Abstract][Full Text] [Related]
47. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
[TBL] [Abstract][Full Text] [Related]
48. Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood.
von Stülpnagel C; Kluger G; Leiz S; Holthausen H
Epilepsy Behav; 2010 Feb; 17(2):193-8. PubMed ID: 20045383
[TBL] [Abstract][Full Text] [Related]
49. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
[TBL] [Abstract][Full Text] [Related]
51. Preliminary efficacy of levetiracetam in monotherapy.
Ben-Menachem E
Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
[TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
[TBL] [Abstract][Full Text] [Related]
53. Levetiracetam for people with mental retardation and refractory epilepsy.
Kelly K; Stephen LJ; Brodie MJ
Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
[TBL] [Abstract][Full Text] [Related]
54. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
Coppola G; Mangano S; Tortorella G; Pelliccia A; Fels A; Romano A; Nardello R; Habetswallner F; Licciardi F; Operto FF; Pascotto A
Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
[TBL] [Abstract][Full Text] [Related]
55. Levetiracetam as a treatment option in non-convulsive status epilepticus.
Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
[TBL] [Abstract][Full Text] [Related]
56. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
Helmstaedter C; Witt JA
Epilepsy Behav; 2010 May; 18(1-2):74-80. PubMed ID: 20462801
[TBL] [Abstract][Full Text] [Related]
57. Levetiracetam in children with refractory status epilepticus.
Gallentine WB; Hunnicutt AS; Husain AM
Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
[TBL] [Abstract][Full Text] [Related]
58. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
59. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
